17β-Estradiol at low concentrations acts through distinct pathways in normal versus benign prostatic hyperplasia-derived prostate stromal cells

Endocrinology

Volumn 150, Issue 10, 2009, Pages 4594-4605

  Park, Irwin I ^a   Zhang, Qiang ^a   Liu, Victoria ^b   Kozlowski, James M ^a   Zhang, Ju ^c   Lee, Chung ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR ALPHA; GPER PROTEIN, HUMAN;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTROSPECTION; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; STROMA CELL; ADOLESCENT; ADULT; AGED; CYTOLOGY; METABOLISM; MIDDLE AGED; PHENOTYPE; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROSTATE; PROSTATIC HYPERPLASIA; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 70349321290     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1591     Document Type: Article

References (39)

1. Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, Nordling J, Roehrborn C, Schulman C, Teillac P, Tubaro A, Nickel JC 2003 Benign prostatic hyperplasia: a progressive disease of aging men. Urology 61:267-273 (Pubitemid 36206514)
2. Thorpe A, Neal D 2003 Benign prostatic hyperplasia. Lancet 361:1359-1367
3. Farnsworth WE 1999 Estrogen in the etiopathogenesis of BPH. Prostate 41:263-274
4. Tsurusaki T, Aoki D, Kanetake H, Inoue S, Muramatsu M, Hishikawa Y, Koji T 2003 Zone-dependent expression of estrogen receptors α and β in human benign prostatic hyperplasia. J Clin Endocrinol Metab 88:1333-1340 (Pubitemid 36337798)
5. Hong JH, Song C, Shin Y, Kim H, Cho SP, Kim WJ, Ahn H 2004 Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth factor-β. Urology 171:1965-1969 (Pubitemid 38501054)
6. Wu Q, Shi J, Chen L, Wang CY, Park I, Lee C, Zhang J 2008 Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner. BJU Int 101:497-502 (Pubitemid 351160939)
7. Zhang Z, Duan L, Du X, Ma H, Park I, Lee C, Zhang J, Shi J 2008 The proliferative effect of 17β-estradiol on human prostate stromal cells is mediated through activation of ERK. Prostate 68:508-516
8. Prins GS, Korach KS 2008 The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73:233-244
9. Shibata Y, Ito K, Suzuki K, Nakano K, Fukabori Y, Suzuki R, Kawabe Y, Honma S, Yamanaka H 2000 Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition. Prostate 42:45-55 (Pubitemid 30004874)
10. Seppelt U 1978 Correlation among prostate stroma, plasma estrogen levels, and urinary estrogen excretion in patients with benign prostatic hypertrophy. J Clin Endocrinol Metab 47:1230-1235 (Pubitemid 9091283)
11. Bjönström L, Sjöberg M 2005 Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19:833-842 (Pubitemid 40397050)
12. Jakacka M, Ito M, Martinson F, Ishikawa T, Lee EJ, Jameson JL 2002 An estrogen receptor (ER) α deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 16:2188-2201 (Pubitemid 35155533)
13. Figtree GA, McDonald D, Watkins H, Channon KM 2003 Truncated estrogen receptor α 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 107:120-126 (Pubitemid 36070943)
14. Wanga MM, Traystmanc RJ, Hurn PD, Liu T 2004 Non-classical regulation of estrogen receptor-α by ICI182,780. J Steroid Biochem Mol Biol 92:51-62 (Pubitemid 39486062)
15. Pawlak J, Karolczak M, Krust A, Chambon P, Beyer C 2005 Estrogen receptor-α is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway. Glia 50:270-275 (Pubitemid 40769856)
16. Manavathi B, Kumar R 2006 Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J Cell Physiol 207:594-604 (Pubitemid 43670418)
17. Prossnitz E, Arterbum J, Sklar L 2007 GPR30: A G protein-coupled receptor for estrogen. Mol Cell Endocrinol 265-266:138-142
18. Tan MO, Karabiyik I, Uygur MC, Diker Y, Erol D 2003 Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia. Int Urol Nephrol 35:357-363 (Pubitemid 39127551)
19. Zhuang TN, Ly LP, Cummin RG, Handelsman DJ 2005 Growth and development during early manhood as determinants of prostate size in later life. J Clin Endocrinol Metab 90:6055-6063
20. Tsai CJ, Cohn BA, Cirillo PM, Feldman D, Stanczyk FZ, Whittemore AS 2006 Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States). Cancer Causes Control 17:1237-1244 (Pubitemid 44772823)
21. Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG 2006 Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15:86-91
22. Roberts R, Jacobson D, Rhodes T, Klee G, Leiber M, Jacobsen S 2004 Serum sex hormones and measures of benign prostatic hyperplasia. Prostate 61:124-131 (Pubitemid 39244699)
23. Krieg M, Nass R, Tunn S 1993 Effect of aging on endogenous level of 5α-dihydrotestosterone, testosterone, 17β-estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 77:375-381 (Pubitemid 23230043)
24. Sensibar JA, Pruden SJ, Kasjanksi RZ, Rademaker A, Lee C, Grayhack JT, Kozlowski JM 1999 Differential growth rates in stromal cultures of human prostate derived from patients of varying ages. Prostate 38:110-117 (Pubitemid 29052949)
25. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Ando' S, Maggliolini M 2006 The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17β-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 20:631-646
26. Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM 2001 Comparative studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 159:79-92 (Pubitemid 33704195)
27. Jeng MH, ten Dijke P, Iwata KK, Jordan VC 1993 Regulation of the levels of three transforming growth factor mRNAs by estrogen and their effects on the proliferation of human breast cancer cells. Mol Cell Endocrinol 97:115-123
28. Pellegrino MJ, Stork PJ 2006 Sustained activation of extracellular signal-regulated kinase by nerve growth factor regulates c-fos protein stabilization and transactivation in PC12 cells. J Neurochem 99:1480-1493
29. 1 phase to allow cell-cycle progression. Curr Biol 16:1171-1182
30. Chalmers CJ, Gilley R, March HN, Balmanno K, Cook SJ 2007 The duration of ERK1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1. Cell Signal 19:695-704 (Pubitemid 46275362)
31. Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato M, Sica V, Bresciani F, Weisz A 1996 17β-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 12:2315-2324 (Pubitemid 26192711)
32. Lavoie JN, L'Allemain G, Brunet A, Müller R, Pouysségur J 1996 Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271:20608-20616 (Pubitemid 26281839)
33. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AN, Ando S, Maggiolini M 2007 G Protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67:1859-1866
34. Teng J, Wang ZY, Prossnitz ER, Bjorling DE 2008 The G-protein-coupled receptor GPR30 inhibits human urothelial cell proliferation. Endocrinology 149:4024-4034
35. Filardo EJ, Quinn JA, Bland KI, Frackelton Jr AR 2000 Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660
36. Liu Z, Yu X, Shaikh ZA 2008 Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium. Toxicol Appl Pharmacol 228:286-294
37. Pruitt K, Ulkü AS, Frantz K, Rojast RJ, Muniz-Medina VM, Rangnekar VM, Der CJ, Shields JM 2005 Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. J Biol Chem 280:23363-23370 (Pubitemid 40853250)
38. Lu R, Wang X, Chen ZF, Sun DF, Tian XQ, Fang JY 2007 Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells. J Biol Chem 282:12249-12259 (Pubitemid 47100721)
39. Zhou W, Park I, Pins M, Kozlowski JM, Jovanovic B, Zhang J, Lee C, Ilio K 2003 Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-β1. Endocrinology 144:4280-4284 (Pubitemid 37204825)